10 results on '"Bath, Sarah C"'
Search Results
2. No effect of modest selenium supplementation on insulin resistance in UK pregnant women, as assessed by plasma adiponectin concentration.
- Author
-
Mao J, Bath SC, Vanderlelie JJ, Perkins AV, Redman CW, and Rayman MP
- Subjects
- Adult, Biomarkers blood, Cross-Sectional Studies, Diabetes, Gestational blood, Female, Humans, Selenium adverse effects, Selenium blood, Trace Elements adverse effects, Adiponectin blood, Dietary Supplements, Insulin Resistance, Pregnancy blood, Selenium pharmacology, Trace Elements pharmacology
- Abstract
Concern has been expressed recently that Se may increase the risk of type 2 diabetes, but this has not been tested in a randomised-controlled trial (RCT) in pregnant women. We took advantage of having stored plasma samples from the Se in Pregnancy Intervention (SPRINT) RCT of Se supplementation in pregnancy to test the effect of Se supplementation on a marker of insulin resistance in UK pregnant women. Because our blood samples were not fasted, we measured plasma adiponectin concentration, a recognised marker of insulin resistance that gives valid measurements in non-fasted samples, as diurnal variability is minor and there is no noticeable effect of food intake. In SPRINT, 230 primiparous UK women were randomised to treatment with Se (60 μg/d) or placebo from 12 weeks of gestation until delivery. We hypothesised that supplementation with Se at a nutritional level would not exacerbate the fall in adiponectin concentration that occurs in normal pregnancy, indicating the lack of an adverse effect on insulin resistance. Indeed, there was no significant difference between the two groups in the change in adiponectin from 12 to 35 weeks (P=0·938), nor when the analysis was restricted to the bottom or top quartiles of baseline whole-blood Se (P=0·515 and 0·858, respectively). Cross-sectionally, adiponectin concentration was not associated with any parameter of Se status, either at 12 or 35 weeks. It is reassuring that a nutritional dose of Se had no adverse effect on the concentration of adiponectin, a biomarker of insulin resistance, in pregnant women of modest Se status.
- Published
- 2016
- Full Text
- View/download PDF
3. Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial.
- Author
-
Rayman MP, Searle E, Kelly L, Johnsen S, Bodman-Smith K, Bath SC, Mao J, and Redman CW
- Subjects
- Adult, Biomarkers analysis, Biomarkers blood, Double-Blind Method, Female, Humans, Incidence, Nails chemistry, Nutritional Status, Pilot Projects, Pre-Eclampsia blood, Pre-Eclampsia epidemiology, Pre-Eclampsia etiology, Pregnancy, Pregnancy Trimester, First, Risk, Selenium analysis, Selenium blood, Selenium deficiency, United Kingdom epidemiology, Yeast, Dried chemistry, Dietary Supplements, Pre-Eclampsia prevention & control, Selenium therapeutic use, Selenoprotein P blood, Vascular Endothelial Growth Factor Receptor-1 blood, Yeast, Dried therapeutic use
- Abstract
Pre-eclampsia is a serious hypertensive condition of pregnancy associated with high maternal and fetal morbidity and mortality. Se intake or status has been linked to the occurrence of pre-eclampsia by our own work and that of others. We hypothesised that a small increase in the Se intake of UK pregnant women of inadequate Se status would protect against the risk of pre-eclampsia, as assessed by biomarkers of pre-eclampsia. In a double-blind, placebo-controlled, pilot trial, we randomised 230 primiparous pregnant women to Se (60 μg/d, as Se-enriched yeast) or placebo treatment from 12 to 14 weeks of gestation until delivery. Whole-blood Se concentration was measured at baseline and 35 weeks, and plasma selenoprotein P (SEPP1) concentration at 35 weeks. The primary outcome measure of the present study was serum soluble vascular endothelial growth factor receptor-1 (sFlt-1), an anti-angiogenic factor linked with the risk of pre-eclampsia. Other serum/plasma components related to the risk of pre-eclampsia were also measured. Between 12 and 35 weeks, whole-blood Se concentration increased significantly in the Se-treated group but decreased significantly in the placebo group. At 35 weeks, significantly higher concentrations of whole-blood Se and plasma SEPP1 were observed in the Se-treated group than in the placebo group. In line with our hypothesis, the concentration of sFlt-1 was significantly lower at 35 weeks in the Se-treated group than in the placebo group in participants in the lowest quartile of Se status at baseline (P= 0·039). None of the secondary outcome measures was significantly affected by treatment. The present finding that Se supplementation has the potential to reduce the risk of pre-eclampsia in pregnant women of low Se status needs to be validated in an adequately powered trial.
- Published
- 2014
- Full Text
- View/download PDF
4. Iodine deficiency in pregnant women living in the South East of the UK: the influence of diet and nutritional supplements on iodine status.
- Author
-
Bath SC, Walter A, Taylor A, Wright J, and Rayman MP
- Subjects
- Adult, Cohort Studies, Cross-Sectional Studies, England, Female, Hospitals, County, Humans, Iodine administration & dosage, Iodine urine, Middle Aged, Nutritional Requirements, Practice Guidelines as Topic, Pregnancy, Pregnancy Trimester, First, Prenatal Care, World Health Organization, Young Adult, Diet adverse effects, Dietary Supplements, Iodine deficiency, Maternal Nutritional Physiological Phenomena, Nutritional Status
- Abstract
Iodine is a key component of the thyroid hormones which are crucial for brain development. Adequate intake of iodine in pregnancy is important as in utero deficiency may have lifelong consequences for the offspring. Data on the iodine status of UK pregnant women are sparse, and there are no such data for pregnant women in the South East of the UK. A total of 100 pregnant women were recruited to a cross-sectional study carried out at the Royal Surrey County Hospital, Guildford, at their first-trimester visit for an ultrasound scan. The participants provided a spot-urine sample (for the measurement of urinary iodine concentration (UIC) and creatinine concentration) and 24 h iodine excretion was estimated from the urinary iodine:creatinine ratio. Women completed a general questionnaire and a FFQ. The median UIC (85·3 μg/l) indicated that the group was iodine deficient by World Health Organisation criteria. The median values of the iodine:creatinine ratio (122·9 μg/g) and of the estimated 24 h iodine excretion (151·2 μg/d) were also suggestive of iodine deficiency. UIC was significantly higher in women taking an iodine-containing prenatal supplement (n 42) than in those not taking such a supplement (P< 0·001). In the adjusted analyses, milk intake, maternal age and iodine-containing prenatal supplement use were positively associated with the estimated 24 h urinary iodine excretion. Our finding of iodine deficiency in these women gives cause for concern. We suggest that women of childbearing age and pregnant women should be given advice on how to improve their iodine status through dietary means. A national survey of iodine status in UK pregnant women is required.
- Published
- 2014
- Full Text
- View/download PDF
5. Iodine supplements during and after pregnancy.
- Author
-
Bath SC, Jolly KB, and Rayman MP
- Subjects
- Female, Humans, Pregnancy, Deficiency Diseases prevention & control, Dietary Supplements, Iodine administration & dosage, Iodine deficiency, Lactation, Pregnancy Complications prevention & control
- Published
- 2013
- Full Text
- View/download PDF
6. Iodine status during child development and hearing ability: a systematic review.
- Author
-
Dineva, Mariana, Hall, Amanda, Tan, Muqiu, Blaskova, Anna, and Bath, Sarah C.
- Subjects
HEARING ,ONLINE information services ,MEDICAL information storage & retrieval systems ,THYROID hormones ,COCHLEA ,CHILD development ,AUDITORY perception ,SYSTEMATIC reviews ,PREGNANT women ,DIETARY supplements ,DESCRIPTIVE statistics ,MEDLINE ,CONGENITAL hypothyroidism ,RESEARCH bias ,IODINE ,SYMPTOMS - Abstract
Iodine, through the thyroid hormones, is required for the development of the auditory cortex and cochlea (the sensory organ for hearing). Deafness is a well-documented feature of endemic cretinism resulting from severe iodine deficiency. However, the range of effects of suboptimal iodine intake during auditory development on the hearing ability of children is less clear. We therefore aimed to systematically review the evidence for the association between iodine exposure (i.e. intake/status/supplementation) during development (i.e. pregnancy and/or childhood) and hearing outcomes in children. We searched PubMed and Embase and identified 330 studies, of which thirteen were included in this review. Only three of the thirteen studies were of low risk of bias or of good quality, this therefore limited our ability to draw firm conclusions. Nine of the studies (69 %) were in children (one RCT, two non-RCT interventions and six cross-sectional studies) and four (31 %) were in pregnant women (one RCT, one cohort study and two case reports). The RCT of iodine supplementation in mildly iodine-deficient pregnant women found no effect on offspring hearing thresholds. However, hearing was a secondary outcome of the trial and not all women were from an iodine-deficient area. Iodine supplementation of severely iodine-deficient children (in both non-RCT interventions) resulted in improved hearing thresholds. Five of six cross-sectional studies (83 %) found that higher iodine status in children was associated with better hearing. The current evidence base for the association between iodine status and hearing outcomes is limited and further good-quality research on this topic is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Iodine status of pregnant women from the Republic of Cyprus.
- Author
-
Cannas, Andrea, Rayman, Margaret P., Kolokotroni, Ourania, and Bath, Sarah C.
- Subjects
EGGS ,FIRST trimester of pregnancy ,CROSS-sectional method ,PREGNANT women ,DIETARY supplements ,QUESTIONNAIRES ,IODINE ,CREATININE ,NUTRITIONAL status ,IODINE deficiency - Abstract
Iodine supply is crucial during pregnancy to ensure that the proper thyroid function of mother and baby support fetal brain development. Little is known about iodine status or its dietary determinants in pregnant women in the Republic of Cyprus. We therefore recruited 128 pregnant women at their first-trimester ultrasound scan to a cross-sectional study. We collected spot-urine samples for the measurement of urinary iodine concentration (UIC, µg/l) and creatinine concentration (Creat, g/l), the latter of which allows us to correct for urine dilution and to compute the iodine-to-creatinine ratio (UI/Creat). Women completed a FFQ and a general questionnaire. We used a General Linear model to explore associations between maternal and dietary characteristics with UI/Creat. The median UIC (105 µg/l) indicated iodine deficiency according to the WHO criterion (threshold for adequacy = 150 µg/l), and the UI/Creat was also low at 107 µg/g. Only 32 % (n 45) of women reported the use of iodine-containing supplements; users had a higher UI/Creat than non-users (131 µg/g v. 118 µg/g), though this difference was NS in the adjusted analysis (P = 0·37). Of the dietary components, only egg intake was significantly associated with a higher UI/Creat in adjusted analyses (P = 0·018); there was no significant association with milk, dairy products or fish intake. Our results suggest that pregnant women in Cyprus have inadequate iodine status and are at risk of mild-to-moderate iodine deficiency. Further research on dietary sources in this population is required. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. systematic review of iodine intake in children, adults, and pregnant women in Europe—comparison against dietary recommendations and evaluation of dietary iodine sources.
- Author
-
Bath, Sarah C, Verkaik-Kloosterman, Janneke, Sabatier, Magalie, Borg, Sovianne ter, Eilander, Ans, Hora, Katja, Aksoy, Burcu, Hristozova, Nevena, Lieshout, Lilou van, Besler, Halit Tanju, and Lazarus, John H
- Subjects
- *
ONLINE information services , *MEDICAL databases , *EGGS , *NUTRITIONAL assessment , *MEDICAL information storage & retrieval systems , *SYSTEMATIC reviews , *NUTRITIONAL requirements , *PREGNANT women , *RISK assessment , *DIETARY supplements , *DAIRY products , *PLANT-based diet , *DESCRIPTIVE statistics , *FISHES , *RESEARCH funding , *MEDLINE , *IODINE , *NUTRITION policy - Abstract
Context Adequate iodine intake is essential throughout life. Key dietary sources are iodized salt and animal products, but dietary patterns in Europe are changing, for example toward lower salt intake and a more plant-based diet. Objective To review iodine intake (not status) in European populations (adults, children, and pregnant women) to identify at-risk groups and dietary sources. Data sources PubMed, Embase, and Cochrane databases, as well as European national nutrition surveys were searched for data on had iodine intake (from dietary assessment) and sources of iodine, collected after 2006. Data selection In total, 57 studies were included, comprising 22 national surveys and 35 sub-national studies. Iodine intake data were available from national surveys of children aged <10 years (n = 11), 11–17 years (n = 12), and adults (n = 15), but data from pregnancy were only available from sub-national studies. Results Iodine intake data are lacking—only 17 of 45 (38%) European countries had iodine-intake data from national surveys. Iodine intake reported from national surveys was below recommendations for: (1) children aged <10 years in 2 surveys (18%), (2) boys and girls aged 11–17 years in 6 (50%) and 8 (68%) surveys, respectively, and (3) adult men and women in 7 (47%) and 12 (80%) surveys, respectively. In pregnant women, intake was below recommendations except where women were taking iodine-containing supplements. Just 32% of national surveys (n = 7) included iodized salt when estimating iodine intake. Milk, dairy products, fish, and eggs were important contributors to intake in many countries, suggesting limited sources in plant-based diets. Conclusion Results are limited by the challenges of dietary assessment for measuring iodine intake. Future national surveys should include iodine intake. Policy makers should consider dietary sources alongside any iodized salt policies when considering methods for improving population iodine intake. Systematic Review Registration PROSPERO 2017 CRD42017075422. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Gestational changes in iodine status in a cohort study of pregnant women from the United Kingdom: season as an effect modifier123
- Author
-
Bath, Sarah C, Furmidge-Owen, Victoria L, Redman, Christopher WG, and Rayman, Margaret P
- Subjects
Adult ,Thyroid Hormones ,Adolescent ,iodine ,Nutritional Status ,Pregnancy and Lactation ,deficiency ,Maternal Nutritional Physiological Phenomena ,United Kingdom ,Cohort Studies ,Young Adult ,Cross-Sectional Studies ,Pregnancy ,Creatinine ,Surveys and Questionnaires ,Dietary Supplements ,Linear Models ,Humans ,Female ,Pregnancy Trimesters ,Seasons ,diet ,Randomized Controlled Trials as Topic - Abstract
Background: Iodine is required throughout pregnancy for thyroid hormone production, which is essential for fetal brain development. Studies of iodine status in pregnant women from the United Kingdom (UK) have focused on early gestation (
- Published
- 2015
10. Systematic review and meta-analysis of the effects of iodine supplementation on thyroid function and child neurodevelopment in mildly-to-moderately iodine-deficient pregnant women.
- Author
-
Dineva, Mariana, Fishpool, Harry, Rayman, Margaret P, Mendis, Jeewaka, and Bath, Sarah C
- Subjects
THERAPEUTIC use of iodine ,THYROID gland physiology ,NEURAL development ,COGNITION in children ,CONFIDENCE intervals ,DIETARY supplements ,GLOBULINS ,MEDICAL information storage & retrieval systems ,IODINE ,LANGUAGE acquisition ,MEDLINE ,META-analysis ,MOTOR ability ,ONLINE information services ,PREGNANT women ,SYSTEMATIC reviews ,TREATMENT effectiveness ,SEVERITY of illness index ,DESCRIPTIVE statistics ,IODINE deficiency ,CHILDREN ,PREGNANCY - Abstract
Background Mild-to-moderate iodine deficiency, particularly in pregnancy, is prevalent; this is of concern because observational studies have shown negative associations with child neurodevelopment. Although neither the benefits nor the safety of iodine supplementation in pregnancy in areas of mild-to-moderate deficiency are well researched, such supplementation is increasingly being recommended by health authorities in a number of countries. Objectives By reviewing the most recent published data on the effects of iodine supplementation in mildly-to-moderately deficient pregnant women on maternal and infant thyroid function and child cognition, we aimed to determine whether the evidence was sufficient to support recommendations in these areas. Methods A systematic review of randomized controlled trials (RCTs), non-RCT interventions, and observational studies was conducted. To identify relevant articles, we searched the PubMed and Embase databases. We defined mild-to-moderate iodine deficiency as a baseline median urinary iodine concentration (UIC) of 50–149 µg/L. Eligible studies were included in meta-analyses. Results In total, 37 publications were included—10 RCTs, 4 non-RCT interventions, and 23 observational studies. Most studies showed no effect of iodine supplementation on maternal or infant thyroid-stimulating hormone and free thyroxine. Most RCTs found that supplementation reduced maternal thyroglobulin and in 3 RCTs, it prevented or diminished the increase in maternal thyroid volume during pregnancy. Three RCTs addressed child neurodevelopment; only 1 was adequately powered. Meta-analyses of 2 RCTs showed no effect on child cognitive [mean difference (MD): −0.18; 95% CI: −1.22, 0.87], language (MD: 1.28; 95% CI: −0.28, 2.83), or motor scores (MD: 0.28; 95% CI: −1.10, 1.66). Conclusions There is insufficient good-quality evidence to support current recommendations for iodine supplementation in pregnancy in areas of mild-to-moderate deficiency. Well-designed RCTs, with child cognitive outcomes, are needed in pregnant women who are moderately deficient (median UIC < 100 µg/L). Maternal intrathyroidal iodine stores should be considered in future trials by including appropriate measures of preconceptional iodine intake. This review was registered at www.crd.york.ac.uk/prospero as CRD42018100277. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.